Introduction
Orofacial clefting (OFC), encompassing clefts of the lip and palate, is a common congenital disorder which occurs with an incidence that has been estimated at 1 in 500-2500 live births (Murray, 2002) . OFC may present as part of a syndrome where structures other than the lip and palate are affected, or as an isolated entity. Attempts to dissect the genetic basis of non-syndromic OFC have proven problematical as both genetic and environmental factors are known to play a role in its pathogenesis; it has been estimated that as many as 14 interacting loci may be involved in non-syndromic clefting (Schliekelman and Slatkin, 2002) . Recent successes in delineating the molecular mechanisms underlying OFC have been driven largely by the analysis of human clefting syndromes. In this regard, mutations in the transcription factor TP63 have been found to underlie five distinct autosomal dominant developmental disorders in man, a subset of which exhibit cleft lip and palate as a defining feature; these disorders include ectrodactyly, ectodermal dysplasia, clefting (EEC) syndrome (MIM 604292) and ankyloblepharon, ectodermal dysplasia, clefting (AEC) syndrome (MIM 106260) (Celli et al., 1999 , McGrath et al., 2001 .
The TP63 gene is a member of the p53 family which encodes at least six protein variants owing to two different transcription start sites and alternative splicing. Three isoforms contain N-terminal transcriptional activation (TA) sequences, while the other three (ΔN) isoforms do not. In addition, alternative splicing towards the carboxy terminus generates three subtypes; α, which encodes a sterile alpha motif (SAM) domain and a transactivation inhibitory domain (TID), and β and γ, from which the SAM and TID domains are absent (van Bokhoven and Brunner, 2002) . The different protein isoforms all display DNA-binding and tetramerisation domains but vary in their ability to transactivate both p53-responsive genes and other Tp63 isoforms, and in their ability to mediate cell cycle arrest and apoptosis (Yang et al., 1998; Ghioni et al., 2002) . The predominant isoform expressed during embryogenesis is thought to be ΔN-Tp63α, which is found in the basal layer of many epithelial tissues (Yang et al., 1999; Laurikkala et al., 2006) . Mice lacking all Tp63 isoforms die at birth and exhibit severe developmental defects including limb truncations, epidermal defects and craniofacial anomalies (Mills et al., 1999; Yang et al., 1999) . The epidermis is thin, fails to stratify and lacks ectodermal appendages such as hairs, whiskers, teeth and several glands including mammary, salivary and lacrimal glands (Mills et al., 1999; Yang et al., 1999) . The epidermal phenotype has been interpreted to result from lack of proliferative potential of the Tp63-deficient epidermal stem cells (Yang et al., 1999) or lack of commitment of the immature ectoderm to epidermal lineages (Mills et al., 1999) . Despite considerable research into the epidermal (Koster, Huntzinger and Roop, 2002; Keyes et al., 2006) and dental anomalies in Tp63 knockout mice (Laurikkala et al., 2006) , the nature of the craniofacial anomalies and their underlying developmental pathogenesis has not been characterised.
Development of the craniofacial complex involves a complex series of events that requires the close co-ordination of programs for cell migration, growth, differentiation, and apoptosis. Neural crest cells, which delaminate from the neural folds, contribute to and migrate through the mesenchymal tissue into the craniofacial region where, by the fourth week of embryonic development in man, they participate in the formation of the frontonasal prominence, the paired maxillary processes, and the paired mandibular processes surrounding the primitive oral cavity. The formation of the nasal placodes by the end of the fourth week of embryogenesis divides the lower portion of the frontonasal prominence into paired medial and lateral nasal processes. Towards the end of the sixth week of development, merging of the medial nasal processes with one another and with the maxillary processes on each side leads to the formation of the upper lip and the primary palate.
The first sign of overt development of the secondary palate occurs during the sixth week of embryogenesis with outgrowth of paired palatal shelves from the maxillary processes. The palatal shelves initially grow vertically down the sides of the tongue but, during the seventh week of development, they elevate to a horizontal position above the tongue, contact and fuse to form a midline epithelial seam which subsequently degenerates to allow mesenchymal continuity across the palate. These fusion processes are complete by the tenth week of embryogenesis. The development of the mammalian secondary palate thereby divides the oronasal space into separate oral and nasal cavities.
To dissect the role of Tp63 during craniofacial development, and to determine why mutation of TP63 contributes to orofacial clefting in humans, we analysed the expression of Tp63 and characterised the craniofacial defects in Tp63-null mice. We demonstrate that loss of Tp63 resulted in increased Bmp signaling in several areas of the facial processes. Consequently down-regulation of the key signaling molecules Fgf8 and Shh led to reduced mesenchymal cell proliferation, regional growth defects and altered morphogenesis of the nasal processes resulting in a bilateral cleft of the upper lip. We also demonstrate that a proliferative defect in the mesenchyme of the maxillary processes at embryonic day 11.5 leads to absence of the entire anterior region of the secondary palate during the initial stage of palatogenesis. Our results provide molecular evidence that Tp63mediated, epithelial-derived signals are crucial during the outgrowth and modeling of the facial processes and in the initial stages of palatal growth.
Materials and methods

Tissue preparation, scanning electron microscopy, immunohistochemistry and in situ hybridisation
The generation and genotyping of the Tp63 −/− mice have been described previously (Yang et al., 1999) . Mice were housed in accredited animal facilities at the University of Manchester. All procedures were approved by local Ethical Review Committees and are licensed under the Animal (Scientific Procedures) Act 1986, issued by the Home Office, Her Majesty's Government, London, United Kingdom. BALB/c-derived Tp63 −/− embryos were obtained by heterozygous matings, the morning of the vaginal plug being considered E0.5. Tissues were fixed in either 4% paraformaldehyde or Bouin's reagent and processed for histological examination, scanning electron microscopy or immunohistochemistry using standard protocols (Dixon et al., 2000; Knight et al., 2006) . Antibodies were obtained from Santa Cruz (SC-8344, SC-8608; California, USA) and R and D systems (activated caspase 3, AF835; Minneapolis, USA). The wholemount and section in situ hybridization protocols have been described previously (Knight et al., 2006 , Wilkinson et al., 1987 . During all assays, wild-type and Tp63-null embryos were treated identically. In particular, during whole-mount in situ hybridization assays to compare gene expression levels, embryos of both genotypes were incubated in the detection reagent for identical periods of time.
Organ culture and cell proliferation assays E13.5 palatal shelves were dissected from Tp63 null mice and wildtype littermates in sterile Dulbecco's MEN/NUT Mix F-12 (Ham) containing 0.05 mM L-glutamate, 0.25 mM glycine and 15 mM Hepes with 1% penicillin-streptomycin and freshly added L-ascorbic sodium salt at 40 µg/ml final concentration and cultured as described previously (Ferguson et al., 1984) . Cell proliferation assays were performed as described previously (Richardson et al., 2006) . Three non-serial sections were counted from three Tp63 −/− and three wildtype embryos, from one or more litters. All assays were analysed by two individuals and the mean value recorded. Mann-Whitney U statistical tests were performed using SPSS 13.0.
Results
ΔNp63α is widely expressed during facial development
To characterise the expression domains of Tp63 during facial development, we performed whole-mount in situ hybridization assays on E9.5-E12.5 mouse embryos. These studies indicated that Tp63 transcripts were widely expressed during facial development and appeared at particularly high levels in the epithelia of the maxillary and mandibular components of the first branchial arch at E9.5, the lateral and medial nasal processes as they fused at E10.5, the leading edges of the upper lip and mandible at E11.75 and the nasolacrimal groove at E12.5 ( Fig. 1 , A-D). Immunostaining using a panel of antibodies directed against all protein isoforms of Tp63 (pan-Tp63; 4A4), ΔN-Tp63 and Tp63α isoforms were identical, confirming previous observations that the main embryonic isoform is ΔN-Tp63α (Yang et al., 1999 , Laurikkala et al., 2006 . Similar experiments using a TA-Tp63-specific antibody failed to detect these isoforms at any of the embryonic stages examined. These observations were confirmed by RT-PCR and real-time PCR (data not shown). We observed strong staining for ΔN-Tp63α in all basal cells of the ectoderm of the facial processes from E9.5 (data not shown). Initially, we detected intense Tp63 staining in basal cells of the ectoderm in the most distal regions of the medial and lateral nasal processes at E10.5 ( Fig. 1E ). Subsequently, this expression domain was confined to only the ectodermal component of the nasal processes at E11.5 ( Fig. 1G ). Staining was present in all basal cells of the ectoderm covering the maxillary processes during E10-E12 ( Fig. 1, F ,H) and at all stages of development of the secondary palate from E11.5 to E14.5 ( Fig. 1 , I-L) and at E15.5 (data not shown).
Tp63 −/− embryos display bilateral cleft lip and cleft palate Tp63 −/− embryos exhibited a fully penetrant bilateral cleft lip and a complete cleft of the secondary palate (n = 137) ( Fig. 2 , A-D). This phenotype was first apparent at E11.5, when the maxillary processes were observed to be smaller in Tp63 −/− mice than in Tp63 +/− or Tp63 +/+ littermates (Fig. 2 , E, F). In addition, the medial nasal processes had a more rounded appearance and failed to meet the lateral nasal processes in the most distal regions (Fig. 2F ). Histological analysis of a developmental series of Tp63 −/− embryos determined that the facial processes were abnormally shaped and the lateral nasal processes and maxillary processes appeared smaller than those of their wild-type littermates (Fig. 2 , G-J). The medial and lateral nasal processes remained apart in all Tp63 −/− embryos examined, although serial sections through Tp63-null embryos revealed that the posterior region of the medial nasal processes fused with the anterior region of the maxillary processes via an "epithelial bridge" (Fig. 2J ). In addition, the defects of the secondary palate were particularly severe in the anterior region, which was completely absent in Tp63 −/− embryos at E12.5 and markedly smaller at E13.5 (Fig. 2 , K-N). Skeletal analysis of E18.5 Tp63 −/− embryos revealed abnormalities of the nasal capsule, absence of the premaxilla and palatal processes of the maxilla and palatine bone ( Fig. 2 , O, P). Although the overall morphology of the Tp63 −/− mice suggested that the defect in palatogenesis occurred as a result of abnormal growth and patterning during early embryogenesis, we confirmed that the palatal shelves were competent to fuse with one another using in vitro organ culture (Ferguson et al., 1984) . Palates from E13.5 wild-type and Tp63 −/− mice were dissected, placed in close proximity and cultured for 24 or 48 h. Histological analysis confirmed that after 24 h all Tp63 −/− explants had fused in the midline and, in most cases, the epithelial seam had started to degenerate (Fig.  2 , Q, R). After 48 h of culture, all Tp63 −/− explants were fully fused with no evidence of a midline epithelial seam (data not shown). These data indicate that the palates of Tp63 −/− mice are capable of fusion and that the cleft palate occurs as a result of failure of growth of the individual palatal shelves.
Tp63-mediated signaling is essential for cell survival
Scanning electron microscopy revealed that the facial processes of wild-type mice were covered by flattened, regular periderm cells, whereas the tips of the lateral nasal processes and the maxillary processes of Tp63 −/− embryos were decorated with rounded irregular cells that appeared to be sloughing away from the underlying epithelium ( Fig. 3 , A-D). These cells were not periderm in nature; indeed, Tp63-null mice do not form a periderm layer as judged by keratin 17 immunofluorescence assays (data not shown). These abnormal cells were evident in histological sections ( Fig. 3 , E-H) and stained positively for activated caspase-3, confirming that the cells were undergoing inappropriate cell death ( Fig. 3 , I, J). We were unable to find any areas of cell death within the mesenchyme of the facial processes or secondary palate in Tp63 −/− embryos ( Fig. 3 , I, J and data not shown). In light of these observations, we hypothesized that while the epithelial cell death might be a contributory factor to the cleft lip, it could not account for the smaller maxilla observed in Tp63 −/− embryos. We therefore analysed neural crest cell migration by examining the expression patterns of the neural crest marker Sox10 (Southard-Smith et al., 1998) . These experiments determined that Sox10 expression patterns were comparable in the Tp63 −/− embryos and their wild-type littermates, indicating that the migration of neural crest cells into the developing branchial arches was unaffected in Tp63 −/− mice (Fig. S1 ).
Tp63 −/− embryos display mesenchymal proliferation defects
To further investigate the pathogenesis of the cleft lip and palate in the Tp63 −/− mice, we analysed cell proliferation in E10.5-E12.5 mutant embryos and their wild-type littermates using BrdU incorporation assays. We hypothesised that for the facial processes to form the correct shape to allow contact and fusion, there were likely to be different proliferation rates in different regions of the facial processes. Thus, the medial nasal, lateral nasal and maxillary processes were divided into sub-regions which were analysed individually. It proved impossible to assess proliferation within the epithelia of the facial processes as it appeared unhealthy and, in many areas, was detached from the mesenchyme (Fig. 2L) . These assays determined that the mesenchyme within the facial processes of E10.5 wild-type embryos and is expressed highly in the fusion region between the medial nasal process and maxillary process (arrowed) (H). (I-L) During development of the secondary palate, Tp63 staining is detected in the ectoderm throughout the oral cavity from E11.5 (I), the developing tooth germs from E12.5 (J), and in the palatal shelves from E12.5 to E14.5 (J-L). fnp, frontonasal process; mnd, mandible; mx, maxillary process; mnp, medial nasal process; lnp, lateral nasal process; p, palate; t, tongue; tg, tooth germ. Scale bars: E-K; 200 µm; L, 100 µm.
was highly proliferative, with the percentage of labelled cells ranging from 42% to 58%. Although there was no significant difference in proliferation within any region of the facial processes of Tp63 −/− mice compared to control littermates at this age, the lateral nasal processes and the maxillary processes had significantly lower total cell counts than those of the wild-type littermates (P values = 0.05; Fig. S2 ). The total cell count in these processes was also significantly lower at E11.5 (P = 0.05; Fig. 4 ). When proliferation rates were assessed at E11.5, three regions of the facial processes in Tp63 −/− embryos were found to contain significantly fewer BrdU-labelled cells; region 4 of the lateral nasal process (P = 0.014), region 2 of the medial nasal processes (P = 0.014), and region 4 of the maxillary processes (P = 0.027, Fig. 4 , L-N). Intriguingly, region 4 of the maxillary process is the medial aspect from which the palatal shelves emerge late on E11. These data led us to extend our studies to the next stage of palate development. After comparisons of the morphology of the wild-type and Tp63 −/− embryos at E12.5, we were unable to find any evidence of palatal shelf outgrowth from the anterior maxillary processes of Tp63 −/− embryos. We therefore divided the mid and posterior palate into medial and lateral regions. At E12.5, we demonstrated that the posterior palate contained significantly fewer cells, predominantly due to a significantly lower total cell count in the medial aspect (P = 0.05, Fig. S3, G) , although both the medial and lateral aspects of the posterior palate were significantly more proliferative (P = 0.05, Fig. S3, H) .
Altered signaling in the facial processes of p63 −/− embryos To analyse the molecular events underlying the facial clefting observed in Tp63 −/− mice, we performed whole-mount in situ hybridization on E10.5 to E12.5 mouse embryos, focussing on key signaling molecules known to be important during facial morphogenesis, including members of the Bmp, Shh and Fgf families (Wilkie and Morriss-Kay, 2001; Richman and Lee, 2003) . At E10.5 and E11.5 the secreted signaling molecule Bmp4 is expressed at low levels in the epithelia covering the medial and lateral nasal processes and maxillary and mandibular processes in wild-type embryos . In contrast, in Tp63 −/− embryos, Bmp4 transcripts appeared markedly elevated in the epithelium of the caudal region of the lateral nasal processes at E10.5 and in the anterior region of the maxillary processes at E10.5 and E11.5 (Fig. 5, A-D) . Alterations in Bmp signaling have previously been shown to affect the expression of Fgf8 (Barlow et al., 1999; Shigetani et al., 2000) , which is expressed in both complementary and overlapping domains with Bmp4 (Crossley and Martin, 1995) . At E10.5 and E11.5, Fgf8 expression was detected in the epithelia of the medial and lateral nasal processes and the maxillary and mandibular processes of wild-type embryos. In Tp63 −/− embryos, however, we observed marked changes in Fgf8 expression. At E10.5, Fgf8 transcripts were absent from the epithelia covering the distal tips of the medial nasal processes, the entire lateral nasal processes and the anterior region of the maxillary processes (Fig. 5, E, F) . At E11.5, Fgf8 expression was absent from the epithelia of the anterior maxillary processes and was down-regulated in the rostral region of the lateral nasal processes (Fig. 5, G, H) . All of these epithelial regions overlie areas of the mesenchyme in which we identified a proliferative defect (Fig. 4, L-N) . To investigate the downstream consequences of the loss of Fgf8 expression, we examined the expression of the Fgf8 target gene, Barx1 (Barlow et al., 1999) . These assays determined that the medially located expression domains of Barx1 were reduced in the mesenchyme of the Tp63 −/− maxillary processes, although a more lateral expression domain was still present in posterior regions (Fig. 5 , I, J). Subsequently, we examined the expression pattern of Shh, which is expressed in the ectoderm of the facial primordia (Echelard et al., 1993; Hu and Helms, 1999) and has been shown to interact with BMP and Msx1 in regulating mammalian palatogenesis (Zhang et al., 2002) . In Tp63 −/− embryos, we found that expression of Shh was downregulated in the medial nasal processes and roof of the oral cavity, and was absent from the entire maxillary process (Fig. 5, K, L) .
As the major site of altered gene expression appeared to be the anterior region of the maxillary processes, we performed section in situ hybridization to identify the precise regions affected in Tp63 −/− embryos. These studies confirmed that Bmp4 was present at much higher levels in the epithelia of Tp63 −/− embryos, particularly in the medial region of the anterior maxillary processes (Fig. 6, A, B ), corresponding to region 4, in which we identified a proliferative defect in the mesenchyme (Fig. 4, N) . Conversely, Fgf8 expression was lost from this region (Fig. 6, E, F) . In the posterior region of the maxillary processes, Bmp4 was not expressed in wild-type embryos nor Tp63 −/− embryos (Fig. 6, C, D) . Fgf8 expression in the posterior region of the maxillary processes of Tp63 −/− embryos was comparable to that observed in wild-type littermates (Fig. 6, G, H) . Expression of Barx1 appeared to be reduced in the mesenchyme of the anterior region of the maxillary processes of Tp63 −/− embryos, but was unaffected in the posterior region ( Fig. 6 , I-L).
Expression of Msx1, which is localised in the nasal processes and anterior maxillary process in wild-type embryos, appeared slightly up-regulated in the maxillary and medial nasal processes of Tp63 −/− embryos ( Fig. S4 A, B) . Expression domains of additional markers, including the Fgf8 target genes Pyst1 (Kawakami et al., 2003) , Pea3, Erm and Pax3 (Firnberg and Neubuser, 2002) which are expressed in the nasal processes, as well as Alx4, Dlx5 and Pax9, were unaltered in Tp63 −/− embryos in comparison to wild-type controls ( Fig. S4 and data not shown). Examination of markers expressed during later stages of palatal development including Satb2, Osr2, Pax9 and Shox2 (FitzPatrick et al., 2003; Lan et al., 2004; Yu et al., 2005) indicated that, although the anterior region of the Tp63 −/− palate at E12.5 and E13.5 exhibited abnormal growth, the anterior to posterior patterning of the palatal shelves was unaffected; for example Shox2, which is expressed strongly in the mesenchyme of the anterior palate in wild-type embryos, was expressed in the Tp63 −/− rudimentary palatal shelves at E13.5 (Fig. S4, O, P) . These data confirm that the altered signaling events during outgrowth of the facial processes at E10.5 and E11.5 result in the absence of the entire anterior region of the secondary palate during the initial stage of palatogenesis. At E13.5, although the palatal shelves exhibit rudimentary growth, this is insufficient for the palatal shelves to make contact and fuse, ultimately resulting in a cleft of the secondary palate. Nevertheless, the intrinsic molecular 200 µm; C and D, 20 µm; E and F, 200 µm; G and H, 50 µm; I and J, 100 µm. mechanisms which underlie anterior-posterior patterning are unaffected in Tp63 −/− embryos.
Discussion
Tp63 −/− mice exhibit abnormal facial morphogenesis
In humans, mutations in TP63 have been identified in five distinct developmental disorders including EEC and AEC syndromes, which are characterised by varying degrees of limb abnormalities, ectodermal dysplasias and facial clefting. To dissect the molecular pathogenesis of the facial anomalies resulting from mutation of Tp63, we have analysed Tp63 mutant mice. Loss of all Tp63 isoforms in mice results in severe developmental defects including limb truncations, epidermal defects and facial anomalies (Mills et al., 1999; Yang et al., 1999) . However, with the exception of the epidermal (Koster, Huntzinger and Roop, 2002; Keyes et al., 2006) and dental anomalies (Laurikkala et al., 2006) , the phenotype of the Tp63-null mice has not been analysed in detail. In this study, we have characterised the fully penetrant bilateral cleft lip and cleft palate observed in Tp63 −/− embryos and have determined the underlying mechanisms. Development of the upper lip involves a series of highly co-ordinated, genetically controlled, morphogenetic events, including outgrowth and expansion of the facial processes, programmed cell death, and fusion and subsequent breakdown of the epithelial seam. Perturbation of any of these tightly controlled steps may result in cleft lip. Central to all of these steps is the establishment of correct facial morphogenesis; indeed, embryos derived from the A/J and CL/Fr strains of mice, which have a high Fig. 4 . Cell proliferation in the facial processes of Tp63 −/− embryos at E11.5. (A-J) Immunohistochemistry of coronal sections using an anti-BrdU antibody. The regions of the medial nasal, lateral nasal and maxillary processes were defined by the dashed lines as illustrated in panels A-D, and divided into regions as illustrated in panels panels E-J. (K) Total mesenchymal cell counts of the entire facial processes. When compared to wild-type littermates (blue columns), Tp63 −/− embryos (yellow columns) have significantly fewer cells in the lateral nasal processes and maxillary processes. Proliferation assays indicate that three regions of the facial processes of Tp63 −/− embryos have significantly fewer BrdU-labelled cells; region 4 of the lateral nasal process (P = 0.014) (L), region 2 of the medial nasal process (P = 0.014) (M), and region 4 of the maxillary process (P = 0.027) (N). These regionallyspecific differences are masked when the processes are analysed as a whole. Error bars are illustrated; an asterisk denotes a significant finding using a Mann-Whitney U statistical test. mx, maxillary process; mnp, medial nasal process; lnp, lateral nasal process. Scale bars: A and B, 300 µm; C and D, 200 µm; E-J, 100 µm. frequency of spontaneous cleft lip, have more prominent and medially convergent medial nasal processes (Millicovsky et al., 1982; Trasler and Ohannessian, 1983) . We observed that the medial nasal processes of Tp63 −/− embryos at E11.5 were extremely rounded at their leading edges, and were distinctly more prominent. Total cell counts revealed that the lateral nasal processes and the developing maxillary processes of Tp63 −/− embryos were significantly smaller than those of the wild-type littermates at E10.5 and E11.5. We excluded the possibility that these defects arise from altered neural crest cell migration or from increased cell death in the mesenchyme of the facial processes and identified three areas of significantly reduced mesenchymal cell proliferation at E11.5. As Tp63 is expressed in the basal cells of the epithelia covering the facial processes, these data indicate that the loss of Tp63 significantly disrupts epithelial signaling during outgrowth of the facial processes, resulting in two distinct but related facial defects, cleft lip and cleft secondary palate.
The origin of the cleft lip in Tp63 −/− mice During the critical stages of outgrowth of the facial processes in Tp63 −/− embryos we observed marked changes in the expression levels of key signaling molecules, including Bmp4 and Fgf8. The BMPs are a group of secreted signaling molecules of the TGFβ superfamily which regulate diverse developmental processes including cell proliferation, apoptosis, differentiation and tissue morphogenesis (Wozney, 1998) . Regulation of BMP signaling is complex; for example, BMPs frequently stimulate transcription of their own antagonists (Merino et al., 1998; Stottmann et al., 2001; Laurikkala et al., 2003) . In the chick, Ashique and co-workers observed that BMP signaling is required to stimulate proliferation and outgrowth of branchial arch mesenchyme, but also observed that the chick globular process and anterior maxillary prominence respond to increased BMP levels by programmed cell death (Ashique et al., 2002) . This is particularly intriguing as we found wide-spread apoptotic cell death in the epithelia covering the caudal region of the lateral nasal processes and most rostral region of the maxillary processes in Tp63 −/− embryos at E11.5. These areas of cell death correlated precisely with regions of increased Bmp4 expression (compare Fig. 3, D and Fig. 5, D) . During development of the upper lip apoptosis is tightly regulated, with dying cells only being observed in the epithelia of the fusing medial and lateral nasal processes and maxillary processes at E11.5 . This tight regulation ensures that apoptosis does not occur before the facial processes have made contact. Examination of chick facial primordia using scanning electron microscopy has indicated that the lateral nasal processes exhibit a region of apoptosis on the medial surface that likely correlates with elevated BMP4 expression (Cox, 2004) . As several studies have linked BMP signaling with cell death (Barlow and Francis-West, 1997; Graham et al., 1994; Zhou and Niswander, 1996) , we conclude that the increased cell death observed in Tp63 −/− mutants is a direct consequence of elevated Bmp signaling (Fig. 5, A-D) . We also observed loss of Fgf8 signaling in the epithelia of the nasal and maxillary processes and identified proliferative defects in the mesenchyme underlying these regions in Tp63-null embryos. This is extremely significant as Fgf8 expression within the facial processes has been correlated with high levels of cell proliferation and expansion of the frontonasal mass mesenchyme (McGonnell et al., 1998; Bachler and Neubüser, 2001) . In addition, ectopic application of Fgf8 has been shown to be capable of substituting for the facial ectoderm in order to stimulate proliferation, promote cell survival and regulate gene expression in the facial mesenchyme (Firnberg and Neubuser, 2002) . Conversely, stripping of the epithelium decreases proliferation Helms, 1999, Schneider et al., 2001) . Our results therefore provide evidence that the cleft lip observed in Tp63 −/− mice results from a combination of inappropriate cell death in the lateral nasal process and maxillary processes, together with reduced proliferation in the medial and lateral nasal processes and maxillary processes. Interestingly, there are few genetic models of cleft lip with or without cleft palate; those that have been reported exhibit a wide variety in the penetrance of clefting (Juriloff and Harris, 2008) . The fully penetrant cleft lip phenotype characterised here is reminiscent of that observed in mice with conditional ablation of Bmpr1a signaling (Liu et al., 2005) . Nestin cre;Bmpr1a mice displayed elevated apoptosis, not only in the epithelium of the medial nasal process, but also extending into the underlying mesenchyme (Liu et al., 2005) . Whether the cleft lip arises from increased Bmp signaling, as we have identified in our study, or loss of Bmp signaling, it is clear that the emerging network linking Tp63 and BMP signaling, which has also been documented in other model organisms (Bakkers et al, 2002) and developmental systems (Laurikkala et al., 2006) is essential in the regulation of proliferation and apoptosis in the developing facial processes.
The altered signaling events in the maxillary process underlie the cleft secondary palate in Tp63 −/− mice Our section in situ hybridization data allowed us to demonstrate that the altered signaling events in the developing facial processes also had a deleterious affect upon the secondary palate. At E11.5, Bmp4, which is expressed in the anterior palate only (Zhang et al., 2002) , was markedly up-regulated in the epithelia of the maxillary processes of Tp63 −/− embryos. Fgf8 expression, by comparison, was lost from this region in Tp63 −/− embryos. We also observed a significant mesenchymal proliferative defect in the anterior medial region of the developing maxillary processes, which subsequently affected the initial stages of palatogenesis. In the posterior region of the maxillary processes where Bmp4 is not expressed, Fgf8 signaling and, consequently, growth and patterning in the posterior region of the palate in Tp63 −/− embryos appeared to be unaffected. While expression of Fgf8 has not been reported for any of the later stages of palatal growth, we postulate that expression of Fgf8 in the maxillary processes at E11.5 acts to initiate palatal shelf outgrowth. This signal is deficient in Tp63-null mice, leading to a lack of the anterior palate at E12.5 and ultimately results in a cleft secondary palate. Tp63-null mice also exhibited loss of Barx1 expression, which has previously been shown to result from perturbation of BMP/Fgf8 signaling (Barlow et al,. 1999 ) and down-regulation of Shh, which is essential for the survival and proliferation of facial mesenchyme cells (Hu and Helms, 1999; Ahlgren and Bronner-Fraser, 1999; Jeong et al., 2004) and has important roles in both tooth germ and palate development (Zhang et al., 2000 (Zhang et al., , 2002 . Taken together, our data uncover a crucial role for Tp63 in the regulation of Bmp, Shh and Fgf8 signaling during facial development. In this regard, it is interesting to note that a recent study of Tp63-bound genes included those involved in cell adhesion, proliferation and cell death and included members of the Notch, Wnt and Tgfβ signaling pathways, including SMO, BMP1, BMP 7, TGFβ1 and TGFβR3 (Yang et al., 2006) . Exactly how Tp63 regulates the expression of Bmp4, Fgf8 or Shh during facial development is currently unknown. In this regard, however, chromatin immunoprecipitation studies have indicated that Tp63 binds directly to Shh, whose expression is induced in response to overexpression of Tp63 in vitro, and is down-regulated in fibroblasts extracted from Tp63 −/− mice (Caserta et al., 2006) . In addition, previous reports suggested that Fgf8 transcripts were severely down-regulated/absent in Tp63 mutant limb buds (Yang et al., 1999 , Mills et al., 1999 , while other studies demonstrated both Fgf8 and Shh expression in the Tp63 mutant dental lamina (Laurikkala et al., 2006) . To understand fully the role of Tp63, it will be important to determine how Tp63 regulates its target genes during facial, dental and limb development versus its role in maintaining tissue-specific functions in the "stem cell niche" or in preventing differentiation during epidermal development (Senoo et al., 2007) .
Recently, analysis of the mechanisms underlying cleft lip and palate in knockout mice has helped to define the genetic pathways governing fusion of the lip and palate. Simultaneously, analysis of DNA samples from syndromic cases of cleft lip and palate has identified previously uncharacterised genes, such as IRF6, in which mutations cause orofacial clefting (Kondo et al., 2002) . In addition, analysis of DNA samples from non-syndromic cleft lip and palate patients has indicated minor roles for mutations in MSX1, FOXE1, GLI2, MSX2, SKI, and SPRY2 in the susceptibility for orofacial clefting (Riley et al., 2007) . Furthermore, polymorphisms in IRF6 have been found to be strongly associated with non-syndromic cleft lip and palate and account for approximately 12% of clefting (Zucchero et al., 2004) . Identification of further Tp63 targets involved in controlling the balance between apoptosis and proliferation during outgrowth of the facial processes may reveal important information that furthers our knowledge of facial morphogenesis and how this is perturbed in orofacial clefting.
